Bayer | BAYN - Current Liabilities


Bayer reported EUR29.4B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Air Liquide EUR 11.46B 2.7B Jun/2026
Akzo Nobel EUR 4.37B 56M Sep/2026
Alcon AG USD 3.17B 163M Jun/2026
Amarin USD 175.14M 10.94M Sep/2026
Arkema EUR 2.98B 176.6M Sep/2026
AstraZeneca USD 31.27B 286M Sep/2026
BASF EUR 18.29B 2.62B Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Beiersdorf EUR 3.72B 209M Jun/2026
Corteva USD 11.45B 661M Sep/2026
Covestro EUR 3.66B 204M Jun/2026
Essilor EUR 12.64B 490M Jun/2026
Fresenius EUR 8.08B 986M Sep/2026
Fresenius Medical Care EUR 7.91B 727.93M Sep/2026
Genmab DKK 1.14B 38M Jun/2026
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 20.72B 814M Sep/2026
GRIFOLS EUR 2.3B 59M Sep/2026
Henkel EUR 9.94B 1.53B Jun/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.53B 211M Jun/2026
Linde USD 15.64B 252M Sep/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 8.96B 833M Sep/2026
Novartis USD 32.52B 777M Sep/2026
Nutrien USD 10.81B 818M Sep/2026
Philips EUR 7.91B 485M Sep/2026
PPG Industries USD 5.22B 8M Sep/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 29.77B 2.16B Sep/2026
SAP EUR 19.11B 624M Sep/2026
Solvay EUR 1.82B 36M Sep/2026
UCB EUR 4.4B 470M Dec/2025
Umicore EUR 4.55B 293.7M Jun/2026
Vinci EUR 59.23B 1.14B Jun/2026